Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Optimal ALT threshold for the automated diagnosis of MASLD: A population-based study using iLFT
Jeremy Lee; Christopher J. Byrne; Paul N. Brennan; Iain MacPherson; Eleanor Dow; John F. Dillon;
Ann Hepatol. 2024;29:
Prevalence and risk factors of significant fibrosis in chronic hepatitis B patients with concurrent metabolic dysfunction-associated steatotic liver disease
Shan Hong; Yiwei Hao; Lei Sun; Ping Li; Junru Yang; Fuyang Zhang; Lingling He; Jing Zhang; Hongshan Wei;
10.1016/j.aohep.2024.101589
The steatosis-associated fibrosis estimator (SAFE) outperformed the FIB-4 score in screening the population for liver disease
Mingkai Li; Ying Lin; Hongsheng Yu; Weichun Lin; Jianning Chen; Yidong Yang; Bin Wu;
10.1016/j.aohep.2024.101516